Strekin AG
PrivateLast Round
Series A
Sep 3, 2019
Total Funding Raised
$13.16M
Company Overview
Strekin AG is a clinical-stage biopharmaceutical company that develops novel therapeutics for diseases involving cell stress-related inflammatory pathways.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Strekin AG Comparables
Compare Strekin AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acousia Therapeutics GmbH | 88% | |
| AudioCure Pharma | 85% | |
| Sound Pharmaceuticals, Inc. | 85% | |
Strekin AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 3, 2019 | ||||
| Seed | May 31, 2017 | ||||
| Seed | Mar 1, 2016 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 7, 2025
Monthly visitors grew 1052% MoM, from 211 to 2.4K.
- May 2, 2025
Monthly visitors grew 336% MoM, from 211 to 919.
Strekin AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Strekin AG's valuation, stock price, and market status.